Steve Miller is Chief Op. & Scientific Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 921,996 shares of CPRX, which is worth approximately $19.9 Million. The most recent transaction as insider was on Dec 13, 2024, when has been sold 235,000 shares (Common Stock, par value $0.001 per share) at a price of $4.01 per share, resulting in proceeds of $942,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 922K
36.57% 3M change
15.62% 12M change
Total Value Held $19.9 Million

Steve Miller Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2024
BUY
Exercise of conversion of derivative security
$942,350 $4.01 p/Share
235,000 Added 20.31%
921,996 Common Stock, par valu...
Dec 10 2024
SELL
Open market or private sale
$1,096,500 $21.93 p/Share
50,000 Reduced 6.78%
686,996 Common Stock, par valu...
Dec 10 2024
BUY
Exercise of conversion of derivative security
$200,500 $4.01 p/Share
50,000 Added 6.35%
736,996 Common Stock, par valu...
Dec 09 2024
BUY
Exercise of conversion of derivative security
-
11,872 Added 1.7%
686,996 Common Stock, par valu...
Aug 20 2024
SELL
Open market or private sale
$3,052,500 $20.35 p/Share
150,000 Reduced 18.18%
675,124 Common Stock, par valu...
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
13,667 Added 1.63%
825,124 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
14,000 Added 1.7%
811,457 Common Stock, par valu...
Dec 11 2023
BUY
Exercise of conversion of derivative security
$169,499 $1.13 p/Share
150,000 Added 15.83%
797,457 Common Stock, par valu...
Dec 05 2023
SELL
Open market or private sale
$569,600 $14.24 p/Share
40,000 Reduced 5.82%
647,457 Common Stock, par valu...
May 11 2023
BUY
Exercise of conversion of derivative security
$79,000 $0.79 p/Share
100,000 Added 12.7%
687,457 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
13,666 Added 2.27%
587,457 Common Stock, par valu...
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
20,000 Added 3.37%
573,791 Common Stock, par valu...
Nov 23 2022
SELL
Open market or private sale
$346,800 $17.34 p/Share
20,000 Reduced 3.49%
553,791 Common Stock, par valu...
Nov 21 2022
SELL
Open market or private sale
$1,222,400 $15.28 p/Share
80,000 Reduced 12.24%
573,791 Common Stock, par valu...
Sep 13 2022
SELL
Open market or private sale
$1,833,782 $16.99 p/Share
107,933 Reduced 14.17%
653,791 Common Stock, par valu...
Aug 18 2022
SELL
Open market or private sale
$2,025,000 $13.5 p/Share
150,000 Reduced 16.45%
761,724 Common Stock, par valu...
Aug 18 2022
BUY
Exercise of conversion of derivative security
$379,500 $2.53 p/Share
150,000 Added 15.9%
793,149 Common Stock, par valu...
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
20,000 Added 2.56%
761,724 Common Stock, par valu...
Aug 25 2021
SELL
Open market or private sale
$444,800 $5.56 p/Share
80,000 Reduced 9.74%
741,724 Common Stock, par valu...
Aug 25 2021
BUY
Exercise of conversion of derivative security
$374,400 $3.12 p/Share
120,000 Added 12.74%
821,724 Common Stock, par valu...
Aug 13 2021
SELL
Open market or private sale
$249,465 $6.09 p/Share
40,963 Reduced 5.52%
701,724 Common Stock, par valu...
Aug 13 2021
BUY
Exercise of conversion of derivative security
$202,800 $3.12 p/Share
65,000 Added 8.05%
742,687 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
20,000 Added 2.87%
677,687 Common Stock, par valu...
SM

Steve Miller

Chief Op. & Scientific Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX